Orexigen Therapeutics Inc (NASDAQ:OREX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Apr 26, 2012 – Jul 14, 2017 · Past |
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past) | EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past |
| David J. Endicott Other companies: Alcon AG (Chief Executive Officer · Since at least Aug 10, 2026); MiniMed Group, Inc. (Director · Since at least Jun 29, 2026); Zeltiq Aesthetics Inc (Director · Apr 25, 2016 – Apr 28, 2017 · Past); Hospira Inc (Pres., Hospira Medical Devices · Mar 10, 2014 – Sep 3, 2015 · Past) | Director · Nov 29, 2012 – Jul 14, 2017 · Past |
| Debora Jorn Other companies: EyePoint, Inc. (EVP, Corp. & Comm'l Dev. · Nov 2, 2016 – Jun 27, 2017 · Past); Viveve Medical, Inc. (Director · Aug 22, 2016 – Jan 3, 2023 · Past); Bausch Health Companies Inc. (EVP, Company Group Chairman · May 20, 2015 – Nov 20, 2015 · Past) | Director · May 20, 2016 – Jul 14, 2017 · Past |
| Michael Narachi Other companies: Ultragenyx Pharmaceutical Inc. (Director · Since at least Feb 20, 2015); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); AMAG Pharmaceuticals Inc (Director · Nov 27, 2007 – May 23, 2013 · Past) | CEO & President, Director · Mar 31, 2009 – Oct 13, 2017 · Past |
| Peter Honig Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Sesen Bio Inc (Director · Jul 20, 2021 – Jun 22, 2022 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past) | Director · Jun 5, 2013 – Jul 14, 2017 · Past |
| Louis C Bock Other companies: Horizon Pharma PLC (Director · Jul 28, 2011 – Aug 2, 2011 · Past); Zogenix Inc (Director · Nov 22, 2010 – Mar 7, 2022 · Past) | Director · May 27, 2010 – Jul 14, 2017 · Past |
| Thomas P Lynch Other companies: BillionToOne, Inc. (See Remarks · Since at least Nov 5, 2025); Nuwellis, Inc. (Chief Legal Compliance Officer · May 20, 2020 – Jan 22, 2021 · Past) | EVP, Chief Admin Off, GC & Sec · Jul 12, 2016 – Oct 13, 2017 · Past |
| Peter D Flynn Other companies: Fate Therapeutics, Inc. (See remarks · Sep 30, 2013 – Jan 5, 2015 · Past) | EVP, Head of Global Dev · Jun 8, 2016 – Oct 13, 2017 · Past |
| Carol A Baum | VP, Commercialization · Feb 27, 2009 – Apr 23, 2009 · Past |
| Mark D Booth | Chief Commercial Officer · Sep 1, 2010 – Feb 26, 2015 · Past |
| Stephen A Moglia | VP & Chief Accounting Officer · Dec 11, 2015 – Mar 15, 2018 · Past |